NL7216281A - - Google Patents

Info

Publication number
NL7216281A
NL7216281A NL7216281A NL7216281A NL7216281A NL 7216281 A NL7216281 A NL 7216281A NL 7216281 A NL7216281 A NL 7216281A NL 7216281 A NL7216281 A NL 7216281A NL 7216281 A NL7216281 A NL 7216281A
Authority
NL
Netherlands
Application number
NL7216281A
Other versions
NL150101B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7216281A publication Critical patent/NL7216281A/xx
Publication of NL150101B publication Critical patent/NL150101B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL727216281A 1971-12-14 1972-11-30 Werkwijze voor het bereiden van 3-aryloxy-2-hydroxypropylaminen met (beta)-adrenergisch blokkerende werking; werkwijze ter bereiding van (beta)-adrenergisch blokkerende farmaceutische preparaten, alsmede de aldus verkregen gevormde voortbrengselen. NL150101B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00207954A US3857891A (en) 1971-12-14 1971-12-14 New aminoalkanol compounds and methods for their production

Publications (2)

Publication Number Publication Date
NL7216281A true NL7216281A (2) 1973-06-18
NL150101B NL150101B (nl) 1976-07-15

Family

ID=22772656

Family Applications (1)

Application Number Title Priority Date Filing Date
NL727216281A NL150101B (nl) 1971-12-14 1972-11-30 Werkwijze voor het bereiden van 3-aryloxy-2-hydroxypropylaminen met (beta)-adrenergisch blokkerende werking; werkwijze ter bereiding van (beta)-adrenergisch blokkerende farmaceutische preparaten, alsmede de aldus verkregen gevormde voortbrengselen.

Country Status (21)

Country Link
US (1) US3857891A (2)
JP (1) JPS5233621B2 (2)
AR (2) AR195896A1 (2)
AT (1) AT317182B (2)
AU (1) AU475446B2 (2)
BE (1) BE790165A (2)
CA (1) CA993889A (2)
CH (1) CH551371A (2)
DK (1) DK134906B (2)
ES (1) ES409565A1 (2)
FI (1) FI55650C (2)
FR (1) FR2163486B1 (2)
GB (1) GB1344976A (2)
HU (1) HU164953B (2)
IE (1) IE37701B1 (2)
IL (1) IL40833A (2)
NL (1) NL150101B (2)
NO (1) NO135244C (2)
SE (1) SE393104B (2)
YU (2) YU35871B (2)
ZA (1) ZA727078B (2)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2119843B1 (2) * 1970-12-28 1974-03-22 Laroche Navarro Labo
JPS5653534B2 (2) * 1973-10-25 1981-12-19
SE388849B (sv) * 1974-02-14 1976-10-18 Haessle Ab Forfarande for framstellning av nya aminer med beta-receptorstimulerande verkan
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
US4080471A (en) * 1976-06-25 1978-03-21 Aktiebolaget Hassle Use of substituted isopropylaminopropanols for inducing inotropic effects of the human heart
JPS56158868A (en) * 1980-05-13 1981-12-07 Satake Eng Co Ltd Ion nitriding treatment device
NZ211815A (en) * 1984-05-15 1988-11-29 Warner Lambert Co Preparation of 1-((3,4-dimethoxyphenethyl)amino)-3- (3-tolyloxy)-2-propanol
US5095151A (en) * 1985-05-21 1992-03-10 American Home Products Corporation Preparation of propranolol hydrochloride macrocrystals
US4789751A (en) * 1985-10-01 1988-12-06 University Patents, Inc. Synthesis of new liquid crystal materials possessing phenylbenzoate or biphenyl core units and (2,3)-epoalkyloxirane methanol chiral tails
JP2587336B2 (ja) * 1991-10-03 1997-03-05 日本ケミファ株式会社 塩酸ベバントロールの製造方法
US5482964A (en) * 1994-10-11 1996-01-09 Warner-Lambert Company Substituted phenoxyhydroxypropyl amines as central nervous system agents
TW467881B (en) * 1997-07-31 2001-12-11 Ying-Jiun Chen Guaiacoxypropanolamines with Α/β-adrenergic blocking activity
WO2000005193A1 (fr) * 1998-07-23 2000-02-03 Chen Ing Jun DERIVES DE GUAIACOXYPROPANOLAMINE A ACTIVITE α/β-ADRENOLYTIQUE
CA2495962A1 (en) 2002-08-19 2004-03-04 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
KR20110117731A (ko) 2003-05-30 2011-10-27 랜박시 래보러터리스 리미티드 치환된 피롤 유도체와 hmg―co 억제제로서의 이의 용도
CN1884251B (zh) * 2005-06-22 2010-06-23 北京德众万全医药科技有限公司 一种盐酸贝凡洛尔的精制方法
CA2627599A1 (en) 2005-11-08 2007-05-18 Ranbaxy Laboratories Limited Process for (3r,5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino)carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
JP6476174B2 (ja) * 2013-06-19 2019-02-27 ソム イノヴェーション バイオテック、ソシエダッド リミターダ 運動過剰障害の予防および/または治療における使用のための治療剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL300886A (2) * 1962-11-23
NL301580A (2) * 1962-12-11
GB1069343A (en) * 1963-09-10 1967-05-17 Ici Ltd Propanolamine derivatives

Also Published As

Publication number Publication date
NL150101B (nl) 1976-07-15
FR2163486B1 (2) 1976-03-05
DK134906B (da) 1977-02-07
DE2259489B2 (de) 1976-02-26
IL40833A0 (en) 1973-01-30
US3857891A (en) 1974-12-31
FR2163486A1 (2) 1973-07-27
CH551371A (fr) 1974-07-15
GB1344976A (en) 1974-01-23
YU36007B (en) 1981-11-13
SE393104B (sv) 1977-05-02
ES409565A1 (es) 1975-12-01
YU35871B (en) 1981-08-31
AT317182B (de) 1974-08-12
FI55650B (fi) 1979-05-31
AU4918672A (en) 1974-05-23
JPS5233621B2 (2) 1977-08-30
AR195896A1 (es) 1973-11-15
DK134906C (2) 1977-06-27
FI55650C (fi) 1979-09-10
IL40833A (en) 1976-01-30
JPS4867232A (2) 1973-09-13
YU301972A (en) 1981-02-28
BE790165A (fr) 1973-02-15
CA993889A (en) 1976-07-27
YU293979A (en) 1981-04-30
IE37701B1 (en) 1977-09-28
NO135244C (2) 1977-03-09
IE37701L (en) 1973-05-14
DE2259489A1 (de) 1973-07-05
NO135244B (2) 1976-11-29
HU164953B (2) 1974-05-28
AU475446B2 (en) 1976-08-26
AR198442A1 (es) 1974-06-21
ZA727078B (en) 1973-06-27

Similar Documents

Publication Publication Date Title
FR2163486B1 (2)
ATA136472A (2)
AR196074A1 (2)
AU2658571A (2)
AU2691671A (2)
AU2742671A (2)
AU2952271A (2)
AU2726271A (2)
AU3005371A (2)
AU2684071A (2)
AU2941471A (2)
AU2894671A (2)
AU2564071A (2)
AU2485671A (2)
AU2473671A (2)
AU2755871A (2)
AU2503871A (2)
AU3038671A (2)
AU2577671A (2)
AU2588771A (2)
AU2654071A (2)
AU2456871A (2)
AU2669471A (2)
AU2455871A (2)
AU2684171A (2)

Legal Events

Date Code Title Description
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: PARKE

V4 Discontinued because of reaching the maximum lifetime of a patent